Ji, W.; Lou, Y.; Jiang, W.G.; Ruge, F.; Martin, T.A.
Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy. Int. J. Mol. Sci. 2025, 26, 5412.
https://doi.org/10.3390/ijms26115412
AMA Style
Ji W, Lou Y, Jiang WG, Ruge F, Martin TA.
Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy. International Journal of Molecular Sciences. 2025; 26(11):5412.
https://doi.org/10.3390/ijms26115412
Chicago/Turabian Style
Ji, Wenxiao, Yufei Lou, Wen G. Jiang, Fiona Ruge, and Tracey A. Martin.
2025. "Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy" International Journal of Molecular Sciences 26, no. 11: 5412.
https://doi.org/10.3390/ijms26115412
APA Style
Ji, W., Lou, Y., Jiang, W. G., Ruge, F., & Martin, T. A.
(2025). Knockdown of Claudin-8 (CLDN8) Indicates a Link Between Breast Cancer Cell Sensitivity to Chemotherapeutics and Reveals a Potential Use of CLDN8 as a Molecular Diagnostic and Target for Therapy. International Journal of Molecular Sciences, 26(11), 5412.
https://doi.org/10.3390/ijms26115412
